Csilla Sipeky
Turku, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
SNP genotypes in CYP2C9 and VKORC1 genes do not affect prostate cancer or cancer mortality among warfarin users in Finnish prostate cancer patients.
Journal: PloS one
Published: November 14, 2024
The 10th Santorini conference: Systems medicine, personalised health and therapy. "The odyssey from hope to practice: Patient first. Keep Ithaca always in your mind", Santorini, Greece, 23-26 May 2022.
Journal: Frontiers in genetics
Published: February 21, 2023
Overview of Registered Clinical Trials on Manual Therapy: Possible Implications of Genetic Testing for Personalized Treatment.
Journal: In vivo (Athens, Greece)
Published: June 11, 2021
Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.
Journal: Nature genetics
Published: January 21, 2021
Rare Germline Variants in ATM Predispose to Prostate Cancer: A PRACTICAL Consortium Study.
Journal: European urology oncology
Published: October 27, 2020
Novel prostate cancer susceptibility gene SP6 predisposes patients to aggressive disease.
Journal: Prostate cancer and prostatic diseases
Published: July 06, 2020
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.
Journal: Nature genetics
Published: May 01, 2020
Prostate cancer risk prediction using a polygenic risk score.
Journal: Scientific reports
Published: February 21, 2020
A Genetic Risk Score to Personalize Prostate Cancer Screening, Applied to Population Data.
Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Published: December 12, 2019
Last Updated: 09/26/2026